… Specifically, this review covers three aspects of dendritic cell (DC) biology connected with
antitumor immune responses but are not specifically oriented toward therapeutic use. First, we …

… Although dendritic cells (DCs) constitute a rare immune cell population within tumours …
cancer immunology and consider the therapeutic potential of targeting DCs in patients with cancer…

… Dendritic cells (DCs) are central regulators of the adaptive immune response, and as
such are necessary for T-cell-mediated cancer immunity. In particular, antitumoral responses …

Dendritic cells (DCs) are professional antigen-presenting cells, orchestrating innate and …
Here, we review both antitumor and tolerogenic DC responses in cancer and discuss lineage-…

… As the initiators and orchestrators of adaptive immune responses, dendritic cells (DCs) are
considered essential to the induction of anti-tumor immune responses. This ability has long …

… , released, or surface-exposed by dying, stressed, or injured cells [2, 3]. Dendritic cells (DCs)
are a minor cell population of distinct subtypes derived from the bone marrow and scattered …

… ) may dictate efficacy of cancer immunotherapies as well as conventional cancer therapies,
… of dendritic cell immunobiology specifically focusing on their role in T-cell priming, migration …

… Dendritic cells (DCs) with their potent antigen presenting ability are long considered as
critical factor in antitumor immunity. Despite high potential in promoting antitumor responses, …

… Inducing effective anti-tumor immunity has become a major therapeutic strategy against
cancer. Dendritic cells (DC) are a heterogenous population of antigen presenting cells that …

… Dendritic cell vaccination enriches tumor milieu and potentiates … dendritic cell vaccines in
different solid tumors regarding their role to improve their clinical efficacy. To date, dendritic cell …